For instance, Stevic et al. (2018) have evaluated miRNA signatures in EXs derived from HER2-positive and triple-negative (TNBC) subtypes of BC and compered them with exosomal miRNAs in healthy women. The gene discussed is ERBB2; the disease is breast cancer.